Pan-viral serology uncovers distinct virome patterns as risk predictors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma

24 Jun 2024
0
0

Pan-viral serology uncovers distinct virome patterns as risk predictors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma

Do WL, Wang L, Forgues M, Liu J, Rabibhadana S, Pupacdi B, Zhao Y, Gholian H, Bhudhisawasdi V, Pairojkul C, Sukeepaisarnjaroen W, Pugkhem A, Luvira V, Lertprasertsuke N, Chotirosniramit A, Auewarakul CU, Ungtrakul T, Sricharunrat T, Sangrajrang S, Phornphutkul K, Budhu A, Harris CC, Mahidol C, Ruchirawat M, Wang XW

Cell Rep Med. 2023;4:101328.

Tags

Share this

Related Posts

One Health drivers of antibacterial resistance: Quantifying the relative impacts of human, animal and environmental use and transmission. Booton RD, Meeyai A, Alhusein N, Buller H, Feil E, Lambert H, Mongkolsuk S, Pitchforth E, Reyher KK, Sakcamduang W, Satayavivad J, Singer AC, Sringernyuang L, Thamlikitkul V, Vass L; OH-DART Study Group, Avison MB, Turner KME. One Health. 2021 Jan 26;12:100220. doi: 10.1016/j.onehlt.2021.100220. eCollection 2021 Jun. PMID: 33644290
26 Jan 2021
0

One Health drivers of antibacterial resistance: Quantifying the relative impacts of human, animal and environmental use and transmission. Booton RD, Meeyai A, Alhusein N, Buller H, Feil E, Lambert H, Mongkolsuk S, Pitchforth E, Reyher KK, Sakcamduang W, Satayavivad J, Singer AC, Sringernyuang L, Thamlikitkul V, Vass L; OH-DART Study Group, Avison MB, Turner KME. One Health. 2021 Jan 26;12:100220. doi: 10.1016/j.onehlt.2021.100220. eCollection 2021 Jun. PMID: 33644290

One Health drivers of antibacterial resistance: Quantifying the relative impacts of human, animal and environmental use and transmission. Booton RD, Meeyai A, Alhusein N, Buller H, Feil E, Lambert H, Mongkolsuk S, Pitchforth E, Reyher KK, Sakcamduang W, Satayavivad J, Singer AC, Sringernyuang L, Thamlikitkul V, Vass L; OH-DART Study Group, Avison MB, Turner KME. One Health. 2021 Jan 26;12:100220. doi: 10.1016/j.onehlt.2021.100220. eCollection 2021 Jun. PMID: 33644290
View More
Paclitaxel delivery using carrier made from curcumin derivative: synergism between carrier and the loaded drug for effective cancer treatment. Amornwachirabodee K, Chiablaem K, Wacharasindhu S, Lirdprapamongkol K, Svasti J, Vchirawongkwin V, Wanichwecharungruang SP*. J Pharm Sci. 2012 Oct;101(10):3779-86.
01 Oct 2012
0

Paclitaxel delivery using carrier made from curcumin derivative: synergism between carrier and the loaded drug for effective cancer treatment. Amornwachirabodee K, Chiablaem K, Wacharasindhu S, Lirdprapamongkol K, Svasti J, Vchirawongkwin V, Wanichwecharungruang SP*. J Pharm Sci. 2012 Oct;101(10):3779-86.

Paclitaxel delivery using carrier made from curcumin derivative: synergism between carrier and the loaded drug for effective cancer treatment. Amornwachirabodee K, Chiablaem K, Wacharasindhu S, Lirdprapamongkol K, Svasti J, Vchirawongkwin V, Wanichwecharungruang SP*. J Pharm Sci. 2012 Oct;101(10):3779-86.
View More

Recent Posts